Eidos Therapeutics (EIDX) News Today → Just Released: Insider's Secret to Trading Options (From Schaeffer’s Research) (Ad) Free EIDX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineThe Anglo File: Game Over for Board Lapses at Eidosthestreet.com - February 3 at 2:45 PMDeus Ex game canceled as nearly 100 Eidos-Montreal staff laid offmsn.com - January 31 at 3:47 PMEmbracer Group reportedly cancels unannounced Deus Ex game, lays off staff at Eidos Montrealmsn.com - January 31 at 3:47 PMEmbracer lays off 97 Eidos employees and cancels new Deus Ex gamemsn.com - January 31 at 3:47 PMEidos Therapeutics Inc (EIDX)investing.com - July 16 at 9:49 AMVTGN - Vistagen Therapeutics, Inc.finance.yahoo.com - June 27 at 12:33 PMEidos' Guardians of the Galaxy Can Still Ride the Wave of Volume 3's May Releasemsn.com - April 7 at 4:21 PMCara Therapeutics Stock (NASDAQ:CARA), Quotes and News Summarybenzinga.com - February 24 at 8:28 PMAdvanced Proteome Therapeutics Corp.: Advanced Proteome Therapeutics Announces Closing of Non-Brokered Private Placementfinanznachrichten.de - December 28 at 7:29 PMSony Eyeing Square Enix Tokyo Purchase Months After Crystal Dynamics, Eidos Montreal Salemsn.com - July 28 at 2:58 AMSony wants to buy Square Enix Tokyo claims Eidos-Montréal foundermsn.com - July 26 at 2:08 PMThe Eidos games that could be revived with the Embracer acquisitionmsn.com - May 2 at 2:11 PMEmbracer agrees to buy Crystal Dynamics, Eidos-Montréal, Square Enix Montréal, and their IPventurebeat.com - May 2 at 4:06 AMVideo-game studio Eidos-Montreal is switching to a 4-day work week for its staff, cutting weekly hours from 40 to 32 while keeping salaries the samemsn.com - October 8 at 9:22 AMEidos-Montréal gambles with entry into "Guardians of the Galaxy" franchisenews.yahoo.com - September 22 at 7:38 PMEidos Therapeutics, Inc. Common Stock (EIDX)nasdaq.com - July 24 at 7:41 PM Get Eidos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EIDX and its competitors with MarketBeat's FREE daily newsletter. Email Address At first glance, this chart looks like nonsense… (Ad)We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates” But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… EIDX Media Mentions By Week EIDX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EIDX News Sentiment▼0.000.43▲Average Medical News Sentiment EIDX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EIDX Articles This Week▼00▲EIDX Articles Average Week Get Eidos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EIDX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Madrigal Pharmaceuticals News Today Organon & Co. News Today BridgeBio Pharma News Today Blueprint Medicines News Today Alpine Immune Sciences News Today Nuvalent News Today Perrigo News Today Alkermes News Today Insmed News Today CymaBay Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EIDX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeGreat Crypto BullWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eidos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
